BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23823935)

  • 1. [Breast cancer diagnosis among women aged 75 and over: study on information delivered by organized breast cancer screening agencies to women reaching the limit age].
    Ecomard LM; Malingret N; Asad-Syed M; Dilhuydy MH; Madranges N; Payet C; Debled M
    Bull Cancer; 2013; 100(7-8):671-6; quiz 677-8. PubMed ID: 23823935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common questions about ductal carcinoma in situ.
    Dell DD
    Am J Nurs; 1997 May; 97(5):61-3, 65-6. PubMed ID: 9155799
    [No Abstract]   [Full Text] [Related]  

  • 6. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.
    Duport N
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):421-30. PubMed ID: 23146369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammography and ultrasound in the diagnosis of contralateral breast cancer.
    Rissanen TJ; Mäkäräinen HP; Apaja-Sarkkinen MA; Lindholm EL
    Acta Radiol; 1995 Jul; 36(4):358-66. PubMed ID: 7619612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening in women aged 50-74 years: is there room for improvement?
    Morère JF; Pivot X; Viguier J; Blay JY; Calazel-Benque A; Coscas Y; Roussel C; Eisinger F
    Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S8-S12. PubMed ID: 21245683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2003 Australian Breast Health Survey: survey design and preliminary results.
    Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
    BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
    Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
    Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast cancer in elderly women].
    Nistri R; Martella B; De Santis L; Spirch S; Militello C; Terranova O
    Chir Ital; 1997; 49(4-5):31-6. PubMed ID: 10392181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing breast disease.
    Chapman B
    CAP Today; 1998 Jul; 12(7):74, 76, 80 passim. PubMed ID: 10181880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ductal carcinoma in situ of the breast].
    Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
    Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient age and tumor size determine the cancer yield of preoperative bilateral breast MRI in women with ductal carcinoma in situ.
    Bae MS; Moon WK; Cho N; Chang JM; Seo M; Park IA; Han W
    AJR Am J Roentgenol; 2013 Sep; 201(3):684-91. PubMed ID: 23971464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast disease: a primer on diagnosis and management.
    Drukker BH
    Int J Fertil Womens Med; 1997; 42(5):278-87. PubMed ID: 9406832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ of the breast in men: a review.
    Pappo I; Wasserman I; Halevy A
    Clin Breast Cancer; 2005 Oct; 6(4):310-4. PubMed ID: 16277880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of ductal carcinoma in situ.
    Hetelekidis S; Schnitt SJ; Morrow M; Harris JR
    CA Cancer J Clin; 1995; 45(4):244-53. PubMed ID: 7600280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of ductal carcinoma in situ.
    Barth A; Brenner RJ; Giuliano AE
    West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.